Related Experiment Video
Updated: May 5, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
ECMO use in infants with bronchopulmonary dysplasia: a literature review
John Ibrahim1, Nicholas Carr2, Franscesca Miquel Verges3
1University of Texas Southwestern Medical Center, Dallas, TX, USA. John.ibrahim@utsouthwestern.edu.
Insights
Extracorporeal membrane oxygenation (ECMO) is being reconsidered for infants with severe bronchopulmonary dysplasia (BPD). Advancements may allow ECMO as a bridge to recovery or lung transplant in select cases.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Cardiopulmonary Support
Background:
- Bronchopulmonary dysplasia (BPD) is a primary cause of chronic respiratory failure in infants.
- Severe BPD necessitates prolonged mechanical ventilation, leading to pulmonary hypertension, high morbidity, and mortality.
- Historically, extracorporeal membrane oxygenation (ECMO) excluded infants with BPD.
Purpose of the Study:
- To reassess the role of ECMO in managing severe bronchopulmonary dysplasia (BPD).
- To evaluate ECMO as a potential rescue therapy for infants with refractory respiratory failure due to BPD.
- To explore ECMO as a bridge to recovery or lung transplantation in select BPD patients.
Main Methods:
- Review of emerging reports and advancements in ECMO technology.
- Analysis of updated anticoagulation strategies and ventilatory management protocols.
- Consideration of patient selection criteria for ECMO in BPD.
Main Results:
- Advancements in ECMO technology and management have led to its reassessment for BPD.
- Emerging evidence suggests ECMO can be a viable option for severe BPD.
- ECMO may serve as a bridge to recovery or lung transplantation for carefully selected infants.
Conclusions:
- ECMO is increasingly considered for severe bronchopulmonary dysplasia (BPD) cases.
- Careful patient selection is crucial, considering pulmonary hypertension, right ventricular function, and lung recovery potential.
- ECMO offers a potential rescue therapy for refractory respiratory failure in infants with BPD.
Abstract:
Bronchopulmonary dysplasia (BPD) is a leading cause of chronic respiratory failure in infants. Severe BPD is associated with prolonged mechanical ventilation, pulmonary hypertension, and high morbidity and mortality. As disease severity increases, extracorporeal membrane oxygenation (ECMO) is being reconsidered as a potential rescue therapy. Historically, ECMO has been reserved for neonates with reversible respiratory failure and those who required mechanical ventilation for less than 14 days, while infants with BPD were excluded. However, advancements in ECMO technology, anticoagulation strategies, and ventilatory management have led to a reassessment of its role in this population. Emerging reports suggest ECMO may serve as a bridge to recovery or lung transplantation for select infants with severe BPD and refractory respiratory failure. Careful patient selection remains critical, considering factors such as pulmonary hypertension severity, right ventricular dysfunction, and potential for lung recovery.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Atelectasis II: Pathophysiology
Chronic Obstructive Pulmonary Disease II: Emphysema

